{"schema_version":"secwatch.filing_event.v1","accession":"0001730463-25-000043","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.504784+00:00","generated_at":"2026-05-20T03:05:09.642005+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"medium","headline":"Autolus sets AGM for June 26; two directors to step down; new equity plan proposed","bullets":["AGM on June 26, 2025; resolutions include adoption of 2024 accounts, auditor reappointment (EY LLP), and director re-elections.","Directors Joseph Anderson and Martin Murphy will not stand for re-election, ending their terms after the AGM.","New Employee Share Purchase Plan with Sharesave Sub-Plan (up to 3M shares) approved by Board on May 20, 2025, subject to shareholder approval.","Remuneration report and policy, plus re-election of Dr. Robert Iannone and Dr. Ravi Rao, also on the agenda."],"urls":{"canonical":"https://secwatch.observer/filing/0001730463-25-000043","json":"https://secwatch.observer/filing/0001730463-25-000043.json","markdown":"https://secwatch.observer/filing/0001730463-25-000043.md","text":"https://secwatch.observer/filing/0001730463-25-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000043/0001730463-25-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000043/autl-20250602.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T03:05:09.642005+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}